Investors Contact Careers

Interpace Biosciences, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
    • Overview
    • Biomarkers Solutions
    • Genomics Services/Molecular Dx
    • Anatomic Path, Flow, and Cytogenetics
    • Integrated Biorepository
    • Bioinformatics Solutions
  • Patients
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics Receives Regional Award as 2018 Top Life Sciences Company

Mar 4, 2019

Interpace Diagnostics Announces Preliminary 2018 Revenues

Feb 28, 2019

Interpace Diagnostics Announces First Independent Publication Demonstrating Clinical Utility of BarreGENĀ®

Feb 19, 2019

Interpace Diagnostics to Attend BIO CEO & Investor Conference in New York City

Feb 4, 2019

Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock

Jan 29, 2019

Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock

Jan 25, 2019

Interpace Diagnostics Announces Proposed Public Offering of Common Stock

Jan 24, 2019

Interpace Diagnostics to Present at the Fifteenth Annual NobleCon

Jan 24, 2019

Interpace Diagnostics Announces Further Expansion of Thyroid Business

Jan 22, 2019

Interpace Diagnostics Enters into Agreement with University of Maryland Medical System

Jan 14, 2019
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...17
    © 2019 Interpace Biosciences, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    • Twitter
    • Facebook
    • Linkedin